Skip to main content

Table 3 Surgical procedure and pathological findings

From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

  n %
Surgery   
  Lower anterior resection 20 52.6%
  Abdominal perineal resection 15 39.5%
  Hartmann 3 7.9%
Lymphatic or vascular invasion   
  Yes 34 89.5%
  No 4 10.5%
Neural invasion   
  Yes 30 78.9%
  No 8 21.1%
Margin   
  Negative 35 92.1%
  Positive 3 7.9%
ypT   
  T0 10 26.3%
  T1 0 0.0%
  T2 7 18.4%
  T3 17 44.7%
  T4 4 10.5%
ypN   
  N0 22 57.9%
  N1 12 31.6%
  N2 4 10.5%
TRG   
  4 6 15.8%
  3 17 44.7%
  2 11 28.9%
  1 4 10.5%
Total 38 100.0%